13.56
price up icon2.57%   0.34
after-market After Hours: 13.48 -0.08 -0.59%
loading
Range Cancer Therapeutics Etf stock is traded at $13.56, with a volume of 3,563. It is up +2.57% in the last 24 hours and down -10.91% over the past month.
See More
Previous Close:
$13.22
Open:
$13.28
24h Volume:
3,563
Relative Volume:
0.97
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.27%
1M Performance:
-10.91%
6M Performance:
-9.75%
1Y Performance:
+29.20%
1-Day Range:
Value
$13.28
$13.70
1-Week Range:
Value
$13.09
$13.70
52-Week Range:
Value
$10.49
$17.96

Range Cancer Therapeutics Etf Stock (CNCR) Company Profile

Name
Name
Range Cancer Therapeutics Etf
Name
Phone
-
Name
Address
-
Name
Employee
0
Name
Twitter
@LoncarFunds
Name
Next Earnings Date
Name
Latest SEC Filings
Name
CNCR's Discussions on Twitter

Compare CNCR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
CNCR 13.56 0 0 0 0 0.00
VTI 296.51 417.53B 0 0 0 0.00
SPY 595.51 372.57B 0 0 0 0.00
IVV 598.45 253.41B 0 0 0 0.00
VB 257.73 160.59B 0 0 0 0.00
QQQ 505.79 124.43B 0 0 0 0.00

Range Cancer Therapeutics Etf Stock (CNCR) Latest News

pulisher
11:07 AM

Regeneron Pharmaceuticals, Inc. (REGN): Among the Most Promising Cancer Stocks According to Hedge Funds - MSN

11:07 AM
pulisher
Nov 21, 2024

Disruptive Theme of the Week – Breakthroughs in Medicine - ETF Trends

Nov 21, 2024
pulisher
Nov 21, 2024

CSHL and Range ETFs launch new partnership - Cold Spring Harbor Laboratory

Nov 21, 2024
pulisher
Nov 19, 2024

(CNCR) Long Term Investment Analysis - Stock Traders Daily

Nov 19, 2024
pulisher
Nov 19, 2024

Trackinsight ETF data from 11th to 15th November, 2024 - ETF Express

Nov 19, 2024
pulisher
Nov 14, 2024

Charted: Cancer Survival Rates Over Time - Visual Capitalist

Nov 14, 2024
pulisher
Nov 11, 2024

Range Cancer Therapeutics - TBR News Media

Nov 11, 2024
pulisher
Nov 11, 2024

How this award-winning TV host is setting the stage to help protect her health - TBR News Media

Nov 11, 2024
pulisher
Nov 10, 2024

Investment fund pledges revenues in cancer research partnership with CSHL - TBR News Media

Nov 10, 2024
pulisher
Nov 09, 2024

(CNCR) Trading Signals - Stock Traders Daily

Nov 09, 2024
pulisher
Nov 06, 2024

At a Glance: Nov. 6 - Crain's New York Business

Nov 06, 2024
pulisher
Nov 03, 2024

7 Best-Performing Biotech ETFs for November 2024 - NerdWallet

Nov 03, 2024
pulisher
Oct 31, 2024

(CNCR) Trading Report - Stock Traders Daily

Oct 31, 2024
pulisher
Oct 29, 2024

The 5 Best Biotech ETFs of 2024 - TradingView

Oct 29, 2024
pulisher
Oct 22, 2024

Microsoft Corp (MSFT-Q) QuotePress Release - The Globe and Mail

Oct 22, 2024
pulisher
Oct 21, 2024

Science & Technology - TBR News Media

Oct 21, 2024
pulisher
Oct 20, 2024

(CNCR) Investment Report - Stock Traders Daily

Oct 20, 2024
pulisher
Oct 14, 2024

5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network

Oct 14, 2024
pulisher
Oct 14, 2024

4 Cancer Stocks to Consider in 2024 - The Motley Fool

Oct 14, 2024
pulisher
Oct 11, 2024

The Zacks Analyst Blog SFYX, CNCR, FXN and DIV - Yahoo Finance

Oct 11, 2024
pulisher
Oct 10, 2024

4 Solid ETFs Under $20 for Your Portfolio - Yahoo Finance

Oct 10, 2024
pulisher
Oct 09, 2024

(CNCR) Investment Analysis - Stock Traders Daily

Oct 09, 2024
pulisher
Oct 04, 2024

Summit Therapeutics: Cancer Drug With Great Potential On 'Fast Track' To US Market (SMMT) - Seeking Alpha

Oct 04, 2024
pulisher
Oct 01, 2024

Trackinsight ETF data from 23rd to 27th September, 2024 - ETF Express

Oct 01, 2024
pulisher
Sep 29, 2024

(CNCR) Investment Analysis and Advice - Stock Traders Daily

Sep 29, 2024
pulisher
Sep 18, 2024

When the Price of (CNCR) Talks, People Listen - Stock Traders Daily

Sep 18, 2024
pulisher
Sep 18, 2024

Breaking Down Acrivon: Deep Dive Into Revenue, Profitability, And Prospects (NASDAQ:ACRV) - Seeking Alpha

Sep 18, 2024
pulisher
Sep 17, 2024

7 Top Gene-Editing Stocks to Buy | Investing - U.S News & World Report Money

Sep 17, 2024
pulisher
Sep 16, 2024

Roundhill Investments Surpasses $2 Billion AUM Milestone – Company Announcement - Financial Times

Sep 16, 2024
pulisher
Sep 10, 2024

5 ETFs That Led the Rebound on Monday - Yahoo Finance

Sep 10, 2024
pulisher
Sep 09, 2024

IPO Roundup: Bicara Therapeutics, Kairos Pharma and more (NYSEARCA:IPO) - Seeking Alpha

Sep 09, 2024
pulisher
Sep 02, 2024

Trading (CNCR) With Integrated Risk Controls - Stock Traders Daily

Sep 02, 2024
pulisher
Aug 30, 2024

Cellectis: Cheap With Promising But Speculative Cancer Therapies (NASDAQ:CLLS) - Seeking Alpha

Aug 30, 2024
pulisher
Aug 28, 2024

Best-Performing ETF Areas of Past Week - MSN

Aug 28, 2024
pulisher
Aug 26, 2024

TScan Therapeutics: Speculative Buy With Near-Term Catalysts In Oncology (TCRX) - Seeking Alpha

Aug 26, 2024
pulisher
Aug 13, 2024

Why It May Be 'Just Right' to Invest in Cancer Therapeutics Development Stocks Now - Nasdaq

Aug 13, 2024
pulisher
Aug 12, 2024

3 Top-Ranked ETFs Under $20 for Your Portfolio - MSN

Aug 12, 2024
pulisher
Aug 07, 2024

Invest in Hope, Invest in Life - Nasdaq

Aug 07, 2024
pulisher
Aug 07, 2024

5 Top-Ranked ETFs to Buy at a Bargain - Yahoo Finance

Aug 07, 2024
pulisher
Aug 06, 2024

Wall Street indexes rise after strong jobs data - Yahoo News Canada

Aug 06, 2024
pulisher
Jul 29, 2024

VIXY Jumped 7.3% Last Week - Yahoo Finance

Jul 29, 2024
pulisher
Jul 29, 2024

SPY Led Inflows Last Week as Leveraged Funds Surged - etf.com

Jul 29, 2024
pulisher
Jul 29, 2024

Best ETFs of Last Week - Yahoo Finance

Jul 29, 2024
pulisher
Jul 28, 2024

US stocks waver, extending tech-led selloff - Yahoo Singapore News

Jul 28, 2024
pulisher
Jul 23, 2024

Time for Healthcare ETFs? - Yahoo Finance

Jul 23, 2024
pulisher
Jul 17, 2024

TSLA-related ETFs among top performing ETFs on a 4-week performance base last week - MSN

Jul 17, 2024
pulisher
Jul 15, 2024

5 Top ETFs of Last Week - Yahoo Finance

Jul 15, 2024
pulisher
Jul 11, 2024

US consumer inflation eases more than expected - Yahoo Singapore News

Jul 11, 2024
pulisher
Jul 10, 2024

How the (CNCR) price action is used to our Advantage - Stock Traders Daily

Jul 10, 2024
pulisher
Jul 08, 2024

GordonMD® Global Investments Portfolio Company, Radionetics Oncology, Announced Strategic Agreement with Lilly - Yahoo Finance

Jul 08, 2024

Range Cancer Therapeutics Etf Stock (CNCR) Financials Data

There is no financial data for Range Cancer Therapeutics Etf (CNCR). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
exchange_traded_fund VTV
$180.08
price up icon 0.73%
exchange_traded_fund VUG
$404.03
price up icon 0.02%
exchange_traded_fund IJH
$66.84
price up icon 1.69%
exchange_traded_fund EFA
$77.56
price up icon 0.39%
exchange_traded_fund IWF
$394.12
price up icon 0.10%
exchange_traded_fund QQQ
$505.79
price up icon 0.16%
Cap:     |  Volume (24h):